HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
486.70
-0.96 (-0.20%)
Dec 5, 2025, 4:00 PM EST - Market closed
HCA Healthcare Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for HCA Healthcare stock have an average target of 463.06, with a low estimate of 370 and a high estimate of 525. The average target predicts a decrease of -4.86% from the current stock price of 486.70.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCA Healthcare stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 2 | 2 | 2 | 6 | 5 |
| Buy | 6 | 6 | 6 | 6 | 7 | 7 |
| Hold | 6 | 8 | 8 | 9 | 9 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 17 | 22 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $412 → $431 | Hold | Maintains | $412 → $431 | -11.44% | Nov 13, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $485 → $525 | Strong Buy | Maintains | $485 → $525 | +7.87% | Oct 28, 2025 |
| UBS | UBS | Strong Buy Maintains $495 → $525 | Strong Buy | Maintains | $495 → $525 | +7.87% | Oct 27, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $430 → $470 | Hold | Maintains | $430 → $470 | -3.43% | Oct 27, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $470 → $520 | Strong Buy | Maintains | $470 → $520 | +6.84% | Oct 27, 2025 |
Financial Forecast
Revenue This Year
76.51B
from 70.60B
Increased by 8.37%
Revenue Next Year
79.92B
from 76.51B
Increased by 4.46%
EPS This Year
27.85
from 22.00
Increased by 26.57%
EPS Next Year
29.96
from 27.85
Increased by 7.58%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 79.9B | 84.6B | ||||
| Avg | 76.5B | 79.9B | ||||
| Low | 73.8B | 75.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 13.2% | 10.6% | ||||
| Avg | 8.4% | 4.5% | ||||
| Low | 4.6% | -1.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 29.63 | 32.99 | ||||
| Avg | 27.85 | 29.96 | ||||
| Low | 25.92 | 26.71 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 34.7% | 18.5% | ||||
| Avg | 26.6% | 7.6% | ||||
| Low | 17.8% | -4.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.